(19)
(11) EP 3 914 289 A1

(12)

(43) Date of publication:
01.12.2021 Bulletin 2021/48

(21) Application number: 19832477.4

(22) Date of filing: 22.11.2019
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
A61K 38/20(2006.01)
A61P 35/00(2006.01)
C07K 16/30(2006.01)
 A61K 38/06(2006.01)
A61K 38/38(2006.01)
C07K 16/28(2006.01)
C07K 16/40(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/3053; C07K 2317/71; A61P 35/00; C07K 16/30; C07K 2319/00; C07K 2317/76; A61K 38/2013; C07K 16/40; A61K 39/0011; A61K 45/06; A61K 2039/545; C07K 16/2818; A61K 2039/507
 
C-Sets:
A61K 38/2013, A61K 2300/00;
(86) International application number:
PCT/US2019/062838
(87) International publication number:
WO 2020/154032 (30.07.2020 Gazette 2020/31)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 23.01.2019 US 201962796013 P

(71) Applicant: Massachusetts Institute of Technology
Cambridge, MA 02139 (US)

(72) Inventors:
  • WANG, Chensu
    Allston, MA 02134 (US)
  • WITTRUP, Karl, Dane
    Boston, MA 02111 (US)
  • IRVINE, Darrell, J.
    Arlington, MA 02476 (US)

(74) Representative: Zwicker, Jörk 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) COMBINATION IMMUNOTHERAPY DOSING REGIMEN FOR IMMUNE CHECKPOINT BLOCKADE